Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EML425 是一种有效的选择性 CREB 结合蛋白 (CBP)/p300 抑制剂,IC50为 2.9 和 1.1 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 378 | 现货 | ||
5 mg | ¥ 911 | 现货 | ||
10 mg | ¥ 1,570 | 现货 | ||
25 mg | ¥ 2,670 | 现货 | ||
50 mg | ¥ 3,890 | 现货 | ||
100 mg | ¥ 5,580 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 983 | 现货 |
产品描述 | EML 425 is a potent and selective inhibitor of CREB binding protein (CBP)/p300 (IC50s: 2.9 and 1.1 μM, respectively). |
靶点活性 | p300:1.1 μM, CBP:2.9 μM |
体外活性 | EML 425 is shown to be a reversible inhibitor, noncompetitive versus both acetyl-CoA and a histone H3 peptide, and able to bind both the free enzyme and the enzyme-substrate complex, even with unequal affinity constants. EML 425, noncompetitive versus both acetyl-CoA and a histone H3 peptide, shows good cell permeability. EML 425 inhibits both p300 and CBP (IC50 values of 2.9 and 1.1 μM, respectively) while being practically inactive against the enzymes general control non-derepressible-5 (GCN5) and p300/CBP-associated factor (PCAF). EML 425 causes a marked and time-dependent reduction in the acetylation of lysine H4K5 and H3K9 in U937 cells. The binding site for EML 425 is an alternative pocket lying near the substrate lysine binding groove and close to the acetylation site[1]. |
分子量 | 440.49 |
分子式 | C27H24N2O4 |
CAS No. | 1675821-32-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (567.55 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2702 mL | 11.351 mL | 22.702 mL | 56.755 mL |
5 mM | 0.454 mL | 2.2702 mL | 4.5404 mL | 11.351 mL | |
10 mM | 0.227 mL | 1.1351 mL | 2.2702 mL | 5.6755 mL | |
20 mM | 0.1135 mL | 0.5675 mL | 1.1351 mL | 2.8377 mL | |
50 mM | 0.0454 mL | 0.227 mL | 0.454 mL | 1.1351 mL | |
100 mM | 0.0227 mL | 0.1135 mL | 0.227 mL | 0.5675 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
EML 425 1675821-32-5 Chromatin/Epigenetic Epigenetic Reader Domain Histone Acetyltransferase HAT HATs EML425 EML-425 inhibit Inhibitor inhibitor